Hypoxia & T Cells: Cancer-Killing Regulator Found
Cancer Treatment Plateau: Scientists Race to Revive Immune Cell Power In a significant development for oncology, the remarkable success of immune checkpoint blockades (ICBs) in treating advanced cancers is facing a critical challenge. While ICBs initially demonstrated unprecedented efficacy, a growing number of patients are exhibiting therapeutic resistance, effectively silencing the body’s natural defenses against … Read more